NTLA Intellia Therapeutics | $9.62
+0.8% | 10/27/2020 | Initiated by | Summer Street | - | Buy | | High | View details for Summer Street rating of Intellia Therapeutics (NASDAQ:NTLA) on 10/27/2020 |
AMD Advanced Micro Devices | $119.50
+4.6% | 1/29/2020 | Upgraded by | Summer Street | - | Neutral -> Buy | | High | View details for Summer Street rating of Advanced Micro Devices (NASDAQ:AMD) on 1/29/2020 |
EBS Emergent BioSolutions | $10.72
+2.2% | 3/6/2015 | Reiterated by | Summer Street | - | Buy | $35.00 | N/A | View details for Summer Street rating of Emergent BioSolutions (NYSE:EBS) on 3/6/2015 |
RMTI Rockwell Medical | $2.06
+2.0% | 1/27/2015 | Target Set by | Summer Street | Analyst James Molloy | Positive -> Buy | $275.00 | N/A | View details for Summer Street rating of Rockwell Medical (NASDAQ:RMTI) on 1/27/2015 |
CARA Cara Therapeutics | $4.91
+2.7% | 12/9/2014 | Initiated by | Summer Street | - | Buy | $240.00 | N/A | View details for Summer Street rating of Cara Therapeutics (NASDAQ:CARA) on 12/9/2014 |
RMTI Rockwell Medical | $2.06
+2.0% | 11/4/2014 | Reiterated by | Summer Street | Analyst James Molloy | Positive | | N/A | View details for Summer Street rating of Rockwell Medical (NASDAQ:RMTI) on 11/4/2014 |
RMTI Rockwell Medical | $2.06
+2.0% | 9/12/2014 | Reiterated by | Summer Street | Analyst James Molloy | Buy | | N/A | View details for Summer Street rating of Rockwell Medical (NASDAQ:RMTI) on 9/12/2014 |
SNN Smith & Nephew | $25.73
+1.4% | 6/5/2014 | Target Raised by | Summer Street | - | Buy | $100.00 -> $112.00 | N/A | View details for Summer Street rating of Smith & Nephew (NYSE:SNN) on 6/5/2014 |
IONS Ionis Pharmaceuticals | $31.64
-1.5% | 5/23/2014 | Reiterated by | Summer Street | - | Neutral | | N/A | View details for Summer Street rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 5/23/2014 |
ZBH Zimmer Biomet | $107.77
-0.4% | 5/19/2014 | Upgraded by | Summer Street | - | Neutral -> Buy | $133.00 | N/A | View details for Summer Street rating of Zimmer Biomet (NYSE:ZBH) on 5/19/2014 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
EBS Emergent BioSolutions | $10.72
+2.2% | 5/15/2014 | Initiated by | Summer Street | - | Buy | $35.00 | N/A | View details for Summer Street rating of Emergent BioSolutions (NYSE:EBS) on 5/15/2014 |
BMY Bristol-Myers Squibb | $59.15
-1.3% | 4/25/2014 | Target Lowered by | Summer Street | - | Buy | $102.50 -> $92.00 | N/A | View details for Summer Street rating of Bristol-Myers Squibb (NYSE:BMY) on 4/25/2014 |
AVDL Avadel Pharmaceuticals | $8.18
+2.6% | 4/9/2014 | Initiated by | Summer Street | - | Positive -> Buy | $25.00 | N/A | View details for Summer Street rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 4/9/2014 |
BMY Bristol-Myers Squibb | $59.15
-1.3% | 3/19/2014 | Target Raised by | Summer Street | - | Buy | $90.00 -> $102.50 | N/A | View details for Summer Street rating of Bristol-Myers Squibb (NYSE:BMY) on 3/19/2014 |
NWBO Northwest Biotherapeutics | $0.29
+2.9% | 3/11/2014 | Target Raised by | Summer Street | - | Buy | $10.33 -> $15.10 | N/A | View details for Summer Street rating of Northwest Biotherapeutics (OTCMKTS:NWBO) on 3/11/2014 |
ANIK Anika Therapeutics | $17.84
+3.2% | 2/26/2014 | Target Raised by | Summer Street | - | Buy | $47.00 -> $60.00 | N/A | View details for Summer Street rating of Anika Therapeutics (NASDAQ:ANIK) on 2/26/2014 |
LGND Ligand Pharmaceuticals | $117.26
+2.2% | 2/24/2014 | Target Raised by | Summer Street | - | Buy | $78.00 -> $91.00 | N/A | View details for Summer Street rating of Ligand Pharmaceuticals (NASDAQ:LGND) on 2/24/2014 |
SNN Smith & Nephew | $25.73
+1.4% | 2/24/2014 | Target Raised by | Summer Street | - | Buy | $80.00 -> $83.00 | N/A | View details for Summer Street rating of Smith & Nephew (NYSE:SNN) on 2/24/2014 |
RMTI Rockwell Medical | $2.06
+2.0% | 2/13/2014 | Reiterated by | Summer Street | - | Buy | | N/A | View details for Summer Street rating of Rockwell Medical (NASDAQ:RMTI) on 2/13/2014 |
GILD Gilead Sciences | $97.99
-0.4% | 2/5/2014 | Reiterated by | Summer Street | - | Buy | | N/A | View details for Summer Street rating of Gilead Sciences (NASDAQ:GILD) on 2/5/2014 |
LGND Ligand Pharmaceuticals | $117.26
+2.2% | 1/27/2014 | Target Raised by | Summer Street | - | Buy | $69.00 -> $78.00 | N/A | View details for Summer Street rating of Ligand Pharmaceuticals (NASDAQ:LGND) on 1/27/2014 |
IMUC EOM Pharmaceuticals | $0.16
| 12/12/2013 | Reiterated by | Summer Street | - | Buy | | N/A | View details for Summer Street rating of EOM Pharmaceuticals (OTCMKTS:IMUC) on 12/12/2013 |
LGND Ligand Pharmaceuticals | $117.26
+2.2% | 11/22/2013 | Target Raised by | Summer Street | - | | $69.00 | N/A | View details for Summer Street rating of Ligand Pharmaceuticals (NASDAQ:LGND) on 11/22/2013 |
RMTI Rockwell Medical | $2.06
+2.0% | 11/6/2013 | Reiterated by | Summer Street | - | Buy | $275.00 | N/A | View details for Summer Street rating of Rockwell Medical (NASDAQ:RMTI) on 11/6/2013 |
ANIK Anika Therapeutics | $17.84
+3.2% | 11/1/2013 | Target Raised by | Summer Street | - | Buy | $28.00 -> $35.00 | N/A | View details for Summer Street rating of Anika Therapeutics (NASDAQ:ANIK) on 11/1/2013 |
VRTX Vertex Pharmaceuticals | $482.28
+2.5% | 10/30/2013 | Downgraded by | Summer Street | - | Buy -> Neutral | | N/A | View details for Summer Street rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 10/30/2013 |
NWBO Northwest Biotherapeutics | $0.29
+2.9% | 9/19/2013 | Initiated by | Summer Street | - | Buy | $10.33 | N/A | View details for Summer Street rating of Northwest Biotherapeutics (OTCMKTS:NWBO) on 9/19/2013 |
EXAS Exact Sciences | $54.75
-0.9% | 9/16/2013 | Initiated by | Summer Street | - | Buy | | N/A | View details for Summer Street rating of Exact Sciences (NASDAQ:EXAS) on 9/16/2013 |
RMTI Rockwell Medical | $2.06
+2.0% | 9/5/2013 | Target Raised by | Summer Street | - | Buy | $220.00 -> $275.00 | N/A | View details for Summer Street rating of Rockwell Medical (NASDAQ:RMTI) on 9/5/2013 |
AMGN Amgen | $289.02
+0.1% | 8/26/2013 | Downgraded by | Summer Street | - | Neutral | | N/A | View details for Summer Street rating of Amgen (NASDAQ:AMGN) on 8/26/2013 |
RMTI Rockwell Medical | $2.06
+2.0% | 8/2/2013 | Reiterated by | Summer Street | - | Buy | $220.00 | N/A | View details for Summer Street rating of Rockwell Medical (NASDAQ:RMTI) on 8/2/2013 |
LGND Ligand Pharmaceuticals | $117.26
+2.2% | 8/2/2013 | Target Raised by | Summer Street | - | Buy | $36.00 -> $64.00 | N/A | View details for Summer Street rating of Ligand Pharmaceuticals (NASDAQ:LGND) on 8/2/2013 |
ANIK Anika Therapeutics | $17.84
+3.2% | 8/2/2013 | Target Raised by | Summer Street | - | Buy | $20.00 -> $28.00 | N/A | View details for Summer Street rating of Anika Therapeutics (NASDAQ:ANIK) on 8/2/2013 |
ZBH Zimmer Biomet | $107.77
-0.4% | 1/30/2013 | Downgraded by | Summer Street | - | Buy -> Neutral | | N/A | View details for Summer Street rating of Zimmer Biomet (NYSE:ZBH) on 1/30/2013 |
BMY Bristol-Myers Squibb | $59.15
-1.3% | 1/23/2013 | Target Raised by | Summer Street | - | Buy | $41.50 -> $61.00 | N/A | View details for Summer Street rating of Bristol-Myers Squibb (NYSE:BMY) on 1/23/2013 |
PBYI Puma Biotechnology | $2.82
+1.1% | 11/15/2012 | Downgraded by | Summer Street | - | Neutral | | N/A | View details for Summer Street rating of Puma Biotechnology (NASDAQ:PBYI) on 11/15/2012 |
BMRN BioMarin Pharmaceutical | $62.87
+0.7% | 11/6/2012 | Target Raised by | Summer Street | - | Buy | $52.00 -> $69.00 | N/A | View details for Summer Street rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 11/6/2012 |
UTHR United Therapeutics | $353.43
-0.3% | 10/24/2012 | Downgraded by | Summer Street | - | Buy -> Neutral | | N/A | View details for Summer Street rating of United Therapeutics (NASDAQ:UTHR) on 10/24/2012 |
IONS Ionis Pharmaceuticals | $31.64
-1.5% | 10/17/2012 | Downgraded by | Summer Street | - | Buy -> Neutral | | N/A | View details for Summer Street rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 10/17/2012 |
BMRN BioMarin Pharmaceutical | $62.87
+0.7% | 9/28/2012 | Target Raised by | Summer Street | - | Buy | $45.00 -> $52.00 | N/A | View details for Summer Street rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 9/28/2012 |
[PDF] Free Cheat Sheet: How to build a dividend portfolio (Ad) Would you like a simple set of guidelines for building a rock solid dividend portfolio?
Including the two specific tickers I just put $50k into?
Well, it’s all included in these FIVE Dividend Cheat Sheets >> You can grab your FREE, laminated copies right here << |
VRTX Vertex Pharmaceuticals | $482.28
+2.5% | 5/8/2012 | Reiterated by | Summer Street | - | Buy | | N/A | View details for Summer Street rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 5/8/2012 |
RMTI Rockwell Medical | $2.06
+2.0% | 4/11/2012 | Initiated by | Summer Street | - | Buy | $220.00 | N/A | View details for Summer Street rating of Rockwell Medical (NASDAQ:RMTI) on 4/11/2012 |
CRIS Curis | $3.47
-0.6% | 1/31/2012 | Target Raised by | Summer Street | - | Buy | $500.00 -> $700.00 | N/A | View details for Summer Street rating of Curis (NASDAQ:CRIS) on 1/31/2012 |
LGND Ligand Pharmaceuticals | $117.26
+2.2% | 1/13/2012 | Initiated by | Summer Street | - | Buy | $22.00 | N/A | View details for Summer Street rating of Ligand Pharmaceuticals (NASDAQ:LGND) on 1/13/2012 |
GILD Gilead Sciences | $97.99
-0.4% | 11/22/2011 | Downgraded by | Summer Street | - | Buy -> Neutral | | N/A | View details for Summer Street rating of Gilead Sciences (NASDAQ:GILD) on 11/22/2011 |
BMRN BioMarin Pharmaceutical | $62.87
+0.7% | 10/31/2011 | Target Raised by | Summer Street | - | Buy | $32.00 -> $40.00 | N/A | View details for Summer Street rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 10/31/2011 |
BMY Bristol-Myers Squibb | $59.15
-1.3% | 10/28/2011 | Target Raised by | Summer Street | - | | $44.50 | N/A | View details for Summer Street rating of Bristol-Myers Squibb (NYSE:BMY) on 10/28/2011 |
CRIS Curis | $3.47
-0.6% | 10/6/2011 | Initiated by | Summer Street | - | Buy | $500.00 | N/A | View details for Summer Street rating of Curis (NASDAQ:CRIS) on 10/6/2011 |
ANIK Anika Therapeutics | $17.84
+3.2% | 9/19/2011 | Initiated by | Summer Street | - | Buy | | N/A | View details for Summer Street rating of Anika Therapeutics (NASDAQ:ANIK) on 9/19/2011 |
ATEC Alphatec | $12.14
+5.9% | 9/19/2011 | Initiated by | Summer Street | - | Buy | | N/A | View details for Summer Street rating of Alphatec (NASDAQ:ATEC) on 9/19/2011 |
AMGN Amgen | $289.02
+0.1% | 8/23/2011 | Initiated by | Summer Street | - | Buy | $49.00 | N/A | View details for Summer Street rating of Amgen (NASDAQ:AMGN) on 8/23/2011 |
BMY Bristol-Myers Squibb | $59.15
-1.3% | 8/17/2011 | Target Raised by | Summer Street | - | Buy | $33.50 -> $35.50 | N/A | View details for Summer Street rating of Bristol-Myers Squibb (NYSE:BMY) on 8/17/2011 |
GILD Gilead Sciences | $97.99
-0.4% | 8/16/2011 | Target Raised by | Summer Street | - | Buy | $42.00 -> $54.00 | N/A | View details for Summer Street rating of Gilead Sciences (NASDAQ:GILD) on 8/16/2011 |
IMUC EOM Pharmaceuticals | $0.16
| 7/28/2011 | Initiated by | Summer Street | - | Buy | $8.00 | N/A | View details for Summer Street rating of EOM Pharmaceuticals (OTCMKTS:IMUC) on 7/28/2011 |
VRTX Vertex Pharmaceuticals | $482.28
+2.5% | 5/24/2011 | Target Raised by | Summer Street | - | Buy | $46.00 -> $72.00 | N/A | View details for Summer Street rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 5/24/2011 |
